Last November, the Vatican convened a meeting with leaders of major pharmaceutical and medical technology companies, multilateral organizations, donors, governments, organizations providing or supporting services for children living with HIV, and other key stakeholders in order to discuss how to reduce morbidity and mortality among children living with HIV

Antimicrobial resistance (AMR) represents a new focus of research for the PENTA-ID network.
At the end of January 2018, Prof Mike Sharland and two members of the PENTA team (Laura Mangiarini and Davide Bilardi) visited Thai and Vietnamese hospitals potentially interested in participating in a AMR research project

Enrollment of patients to the PED-MERMAIDS study is proceeding at a remarkable pace and we have reached 300 patients this month thanks to all sites and their teams.
Specially remarkable the top recruiting site,